Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chiral NSAIDS: so what?

K M Williams1

  • 1Department of Clinical Pharmacology, St. Vincent's Hospital, Sydney, Australia.

Agents and Actions. Supplements
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Single enantiomer NSAIDs show anti-inflammatory effects, but concentration-effect relationships remain unclear. The role of "inactive" enantiomers and disease variability may explain these challenges in clinical studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-omic spatial effects on high-resolution AI-derived retinal thickness.

Nature communications·2025
Same author

Williams KM. Noninfectious complications of hematopoietic cell transplantation. Hematology Am Soc Hematol Educ Program. 2021;2021:578-586.

Hematology. American Society of Hematology. Education Program·2022
Same author

Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM).

European journal of clinical pharmacology·2018
Same author

Search for CP Violation and Measurement of the Branching Fraction in the Decay D^{0}→K_{S}^{0}K_{S}^{0}.

Physical review letters·2017
Same author

A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function.

European journal of clinical pharmacology·2017
Same author

Lepton-Flavor-Dependent Angular Analysis of B→K^{*}ℓ^{+}ℓ^{-}.

Physical review letters·2017
Same journal

Ro 45-2081, a TNF receptor fusion protein, prevents inflammatory responses in the airways.

Agents and actions. Supplements·1998
Same journal

Immunomodulation of Crohn's disease by interleukin-10.

Agents and actions. Supplements·1998
Same journal

Cartilage protective agent (CPA) Ro 32-3555, a new matrix metalloproteinase inhibitor for the treatment of rheumatoid arthritis.

Agents and actions. Supplements·1998
Same journal

Symposium new drugs for inflammatory, allergic and immunologic disease.

Agents and actions. Supplements·1998
Same journal

The complexity of the B7-CD28/CTLA-4 costimulatory pathway.

Agents and actions. Supplements·1998
Same journal

A role for inflammatory cytokines in the productive activation of antigen-specific CD4+ T-cells.

Agents and actions. Supplements·1998
See all related articles

Area of Science:

  • Pharmacology
  • Drug Metabolism and Pharmacokinetics
  • Inflammation Research

Background:

  • Chiral drugs, like NSAIDs, often exhibit enantiomeric differences in pharmacodynamics and pharmacokinetics.
  • Using single enantiomers of chiral NSAIDs is theoretically advantageous over racemic mixtures.
  • Studies on (S)-2-arylpropionates demonstrate anti-inflammatory activity but struggle with concentration-effect relationships.

Purpose of the Study:

  • To investigate the challenges in establishing concentration-effect relationships for single enantiomer NSAIDs.
  • To explore the potential contribution of "inactive" enantiomers to overall drug effects.
  • To identify factors influencing variability in clinical NSAID studies.

Main Methods:

  • Review of existing clinical studies on (S)-2-arylpropionates.

Related Experiment Videos

  • Analysis of pharmacokinetic and pharmacodynamic data.
  • Consideration of disease-related variability and assessment methods.

    • Main Results:

    • Limited clinical studies show anti-inflammatory activity for (S)-2-arylpropionates.
    • Establishing clear concentration-effect relationships remains difficult.
    • Variability in disease factors and assessment methods may impact results.

    Conclusions:

    • The precise role of "inactive" (R)-enantiomers in NSAID therapy requires further investigation.
    • Greater variability in disease states and assessment methods complicates drug effect analysis.
    • Further research is needed to optimize the use of single enantiomer NSAIDs.